Winton Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-80,079
| Closed | -$730K | – | 1065 |
|
|
2022
Q4 | $730K | Buy |
+80,079
| New | +$730K | 0.05% | 514 |
|
|
2022
Q3 | – | Sell |
-35,901
| Closed | -$270K | – | 1083 |
|
|
2022
Q2 | $270K | Buy |
35,901
+13,406
| +60% | +$101K | 0.01% | 826 |
|
|
2022
Q1 | $211K | Buy |
+22,495
| New | +$211K | 0.01% | 902 |
|
|
2019
Q1 | – | Sell |
-260,996
| Closed | -$4.03M | – | 1178 |
|
|
2018
Q4 | $4.03M | Buy |
+260,996
| New | +$4.03M | 0.09% | 275 |
|